![Rank: 9](static/image/common/star_level3.gif) ![Rank: 9](static/image/common/star_level3.gif) ![Rank: 9](static/image/common/star_level1.gif)
- 现金
- 17064 元
- 精华
- 12
- 帖子
- 9399
- 注册时间
- 2007-6-26
- 最后登录
- 2017-11-25
|
Apr 28, 2015
Previous Release PDF Add to Briefcase
Arrowhead to Present at Upcoming Conferences
PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the company will present at the following upcoming investor and scientific conferences.
IBC's 17th Annual TIDES Conference - San Diego, May 3-6, 2015
May 5, 4:45 p.m. PDT - Christine Wooddell, Ph.D., group leader will deliver an oral presentation titled, "A Hepatocyte-Targeted RNAi Therapeutic for Alpha-1-Antitrypsin Deficiency-Associated Liver Disease"
May 6, 12:15 p.m. PDT - David Lewis, Ph.D., chief scientific officer will deliver an oral presentation titled, "A Targeted siRNA-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection"
Deutsche Bank 40th Annual Health Care Conference - Boston, May 6-7, 2015
May 7, 2:50 p.m. EDT - Bruce Given, M.D., chief operating officer will make a corporate presentation
A live webcast of the presentation from the Deutsche Bank conference can be accessed by visiting the Events section of the company's website at http://ir.arrowheadresearch.com/events.cfm. A replay will also be archived on the website. |
|